Cascadian Therapeutics, Inc. Proceeds from Contributed Capital
Cascadian Therapeutics, Inc. reported Proceeds from Contributed Capital of $300.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2018-03-08
- Cascadian Therapeutics, Inc. proceeds from contributed capital for the quarter ending 2016-12-31 was $0.00.
- Cascadian Therapeutics, Inc. proceeds from contributed capital for fiscal 2017 was $300.00K, a 33.33% increase from fiscal 2016.
- Cascadian Therapeutics, Inc. proceeds from contributed capital for fiscal 2016 was $225.00K.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|
| 2017-12-31 | $300.00K 10-K · filed 2018-03-08 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $225.00K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $225.00K 10-Q · filed 2017-11-08 |